fda compounding semaglutide enforcement november 2025 issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Congress Introduces SAFE Drugs Act

Lee co-founded the "Clinical Peptides Society" and started a petition called "Save Peptides" which has garnered nearly 10,000 signatures and urges federal legislators to loosen restrictions on peptides

10.1093/humupd/dmaa043 [DOI] [PubMed] [Google Scholar] Rimle L., Phillips B

30, 2019, pp

By consolidating mechanistic insight, clinical validation, safety profiling, pharmacokinetic challenges, and translational strategies into a unified model, this manuscript aims to provide an evidence-based and clinically actionable framework that extends beyond prior narrative summaries

Serious side effects are rare but may include pancreatitis, gallbladder problems, or thyroid concerns